156 related articles for article (PubMed ID: 30310314)
1. KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer.
Zhang N; Li Z; Xiao W; Yang F; Gao W; Sun ZG
Cancer Manag Res; 2018; 10():3937-3944. PubMed ID: 30310314
[TBL] [Abstract][Full Text] [Related]
2. The KLF6 splice variant KLF6-SV1 promotes proliferation and invasion of non-small cell lung cancer by up-regultating PI3K-AKT signaling pathway.
Zhang N; Yan QQ; Lu L; Shao JB; Sun ZG
J Cancer; 2019; 10(22):5324-5331. PubMed ID: 31632477
[TBL] [Abstract][Full Text] [Related]
3. Roles of Krüppel-like factor 6 splice variant 1 in the development, diagnosis, and possible treatment strategies for non-small cell lung cancer.
Hu K; Ma C; Ma R; Zheng Q; Wang Y; Zhang N; Sun Z
Am J Cancer Res; 2022; 12(10):4468-4482. PubMed ID: 36381325
[TBL] [Abstract][Full Text] [Related]
4. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
[TBL] [Abstract][Full Text] [Related]
5. Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.
Sangodkar J; DiFeo A; Feld L; Bromberg R; Schwartz R; Huang F; Terzo EA; Choudhri A; Narla G
Lung Cancer; 2009 Dec; 66(3):292-7. PubMed ID: 19328586
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the Oncogenic Variant (KLF6-SV1) in Young NPC Patients and Correlation with Lack of E-Cadherin.
Debouki-Joudi S; Mhirsi S; Mokni-Baizig N; Ammous-Boukhris N; Mhamdi H; Gritli S; Gargouri RM; Marzouki MN
Anal Cell Pathol (Amst); 2018; 2018():9654067. PubMed ID: 29854578
[TBL] [Abstract][Full Text] [Related]
7. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
[TBL] [Abstract][Full Text] [Related]
8. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
DiFeo A; Feld L; Rodriguez E; Wang C; Beer DG; Martignetti JA; Narla G
Cancer Res; 2008 Feb; 68(4):965-70. PubMed ID: 18250346
[TBL] [Abstract][Full Text] [Related]
9. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
[TBL] [Abstract][Full Text] [Related]
10. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
11. Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.
Kokhaei P; Hojjat-Farsangi M; Mozaffari F; Moshfegh A; Pak F; Rashidy-Pour A; Palma M; Hansson L; Österborg A; Mellstedt H
PLoS One; 2018; 13(2):e0192839. PubMed ID: 29432497
[TBL] [Abstract][Full Text] [Related]
12. Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.
Wang J; Wang X; Wang Y; Li S; Wang X
Cancer Biol Ther; 2019; 20(5):680-691. PubMed ID: 30590988
[TBL] [Abstract][Full Text] [Related]
13. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
[TBL] [Abstract][Full Text] [Related]
14. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.
Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G
Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610
[TBL] [Abstract][Full Text] [Related]
15. KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model.
Difeo A; Huang F; Sangodkar J; Terzo EA; Leake D; Narla G; Martignetti JA
Cancer Res; 2009 Jun; 69(11):4733-41. PubMed ID: 19435908
[TBL] [Abstract][Full Text] [Related]
16. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma.
Tchirkov A; Sapin V; Marceau G; Chautard E; Narla G; Veronese L; Friedman S; Khalil T; Vago P; Kemeny JL; Verrelle P
Clin Chem Lab Med; 2010 Aug; 48(8):1167-70. PubMed ID: 20545576
[TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic significance of signal transducer and activator of transcription 3 and mucin 1 in patients with non-small cell lung cancer following surgery.
Sun ZG; Zhang M; Yang F; Gao W; Wang Z; Zhu LM
Oncol Lett; 2018 Apr; 15(4):4278-4288. PubMed ID: 29541195
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
20. Cooperativity of c-MYC with Krüppel-Like Factor 6 Splice Variant 1 induces phenotypic plasticity and promotes prostate cancer progression and metastasis.
Izadmehr S; Fernandez-Hernandez H; Wiredja D; Kirschenbaum A; Lee-Poturalski C; Tavassoli P; Yao S; Schlatzer D; Hoon D; Difeo A; Levine AC; Mosquera JM; Galsky MD; Cordon-Cardo C; Narla G
bioRxiv; 2024 Feb; ():. PubMed ID: 38352401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
